22.692 articles found

Severe weight loss in a young Parkinson's disease patient: a multidisciplinary approach to diagnosis and treatment.

Siegert S, Hazan D, Szyper-Kravitz M.

Isr Med Assoc J · 2011-03-01

PMID: 21608345

Abdominal pain: a symptom of levodopa end of dose wearing off in Parkinson's disease.

Rana AQ, Depradine J.

West Indian Med J · 2011-03-01

PMID: 21942133

Generic versus branded pharmacotherapy in Parkinson's disease: does it matter? A review.

Go CL, Rosales RL, Schmidt P, Lyons KE, Pahwa R, Okun MS.

Parkinsonism Relat Disord · 2011-03-01

DOI: 10.1016/j.parkreldis.2011.02.005PMID: 21367644

Elevation of total homocysteine levels in patients with Parkinson's disease treated with duodenal levodopa/carbidopa gel.

Müller T, Jugel C, Ehret R, Ebersbach G, Bengel G, Muhlack S, Klostermann F.

J Neural Transm (Vienna) · 2011-02-27

DOI: 10.1007/s00702-011-0614-9PMID: 21359971

Stem cell challenges in the treatment of neurodegenerative disease.

Feng Z, Gao F.

CNS Neurosci Ther · 2011-02-26

DOI: 10.1111/j.1755-5949.2011.00239.xPMID: 22070610

PROTOFIBRIL-BINDING ANTIBODIES AND THEIR USE IN THERAPEUTIC AND DIAGNOSTIC METHODS FOR PARKINSON'S DISEASE, DEMENTIA WITH LEWY BODIES AND OTHER ALPHA-SYNUCLEINOPATHIES

NORDSTROEM EVA, KASRAYAN ALEX, EKBERG MONICA, SCREPANTI SUNDQUIST VALENTINA, LANNFELT LARS, HOLMQUIST MATS.

· 2011-02-25

Levodopa-carbidopa intestinal gel for treatment of advanced Parkinson's disease.

Fernandez HH, Odin P.

Curr Med Res Opin · 2011-02-25

DOI: 10.1185/03007995.2011.560146PMID: 21351823

The potential application of iron chelators for the treatment of neurodegenerative diseases.

Hider RC, Roy S, Ma YM, Le Kong X, Preston J.

Metallomics · 2011-02-22

DOI: 10.1039/c0mt00087fPMID: 21344071

Deep brain stimulation and frameless stereotactic radiosurgery in the treatment of bilateral parkinsonian tremor: target selection and case report of two patients.

Franzini A, Marchetti M, Brait L, Milanesi I, Messina G, Forapani E, Broggi G, Fariselli L.

Acta Neurochir (Wien) · 2011-02-20

DOI: 10.1007/s00701-011-0962-0PMID: 21336920

Novel therapy in Parkinson's disease: adenosine A(2A) receptor antagonists.

Szabó N, Kincses ZT, Vécsei L.

Expert Opin Drug Metab Toxicol · 2011-02-19

DOI: 10.1517/17425255.2011.557066PMID: 21332415

Therapeutic utility of phosphodiesterase type I inhibitors in neurological conditions.

Medina AE.

Front Neurosci · 2011-02-18

DOI: 10.3389/fnins.2011.00021PMID: 21373359

INHIBITORS OF TGF-R SIGNALING FOR TREATMENT OF CNS DISORDERS

BOGDAHN ULRICH, AIGNER LUDWIG, WACHS FRANK-PETER, WINNER BEATE, WINKLER JUERGEN.

· 2011-02-15